Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (68 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Vaccine Timeline
View:
Post by Kingpin68 on Feb 07, 2022 8:32am

Vaccine Timeline

Great news, but I assumed they would have started testing on animals after 10 months already. I guess they may have had many other candidates to test as well. Hopefully the next phase of testing gets moving now that tld1433 has established itself as having impressive results with serious potential against COVID, and likely any other threatening virus.
Comment by Sunvalley on Feb 07, 2022 8:43am
I would imagine with the initial validation out of the way, events on the Covid front should now accelerate fairly rapidly given the worldwide panic the virus has caused. They should also now be among the first in line for further Government grants and support.
Comment by Legit62 on Feb 07, 2022 8:50am
Great news to come out first, brings us way more exposure and buying before the blockbuster big news of cancer cure that will rocket this ship to the moon. Just booked a hotel room in Vegas for the big party!!!!!
Comment by prophetoffacts on Feb 07, 2022 8:50am
This post has been removed in accordance with Community Policy
Comment by Sunvalley on Feb 07, 2022 8:57am
It would be awesome if TLT were to be given the same rapid consideration that was granted Pfizer , Moderna and J&J at the start of this whole Covid business. Time will tell.
Comment by Gooseybear on Feb 07, 2022 9:06am
It depends on how much TLTFF is willing to bribe the US politicians 
Comment by Lesalpes29 on Feb 07, 2022 9:13am
And the value of vaccins? We can all speculate!
Comment by Oden6570 on Feb 07, 2022 8:59am
If you have followed the progress on this vaccine vertical you will recall TLD1433 has proven highly effective in killing influenza viruses. Just think of the world wide implications opportunities with just the flu alone. And yearly a search for an effective flu vaccine is conducted to find one with a high rate of efficacy. I would say 99.99 % meets the criteria. I can not imagine any serious ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 68 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250